{
    "clinical_study": {
        "@rank": "33355", 
        "arm_group": [
            {
                "arm_group_label": "Tolterodine", 
                "arm_group_type": "Active Comparator", 
                "description": "Tolterodine tartrate extended release capsules + Placebo orally disintegrating tablets"
            }, 
            {
                "arm_group_label": "Combination", 
                "arm_group_type": "Experimental", 
                "description": "Tolterodine tartrate extended release capsules + Desmopressin orally disintegrating tablets"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to investigate the efficacy of combining tolterodine and\n      desmopressin compared with tolterodine monotherapy in the treatment of women with overactive\n      bladder with nocturia in terms of reduction of nocturnal voids during 3 months of treatment"
        }, 
        "brief_title": "Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Overactive Bladder", 
        "condition_browse": {
            "mesh_term": [
                "Nocturia", 
                "Urinary Bladder, Overactive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Written informed consent prior to performance of any trial-related activity\n\n          -  Female sex, at least 18 years of age (at the time of written consent)\n\n          -  Nocturia and overactive bladder symptoms present for \u22656 months prior to trial entry\n             (patient-reported)\n\n          -  At least 2 nocturnal voids each night as documented in 2 diary periods during the\n             screening. A mean of at least 8 daytime voids per day over 3 days with a minimum of\n             at least 6 daytime voids each day as documented in 2 diary periods during the\n             screening. At least 1 urgency episode each 24 hours as documented in 2 diary periods\n             during the screening. Each diary period consists of 3 consecutive days, with at least\n             14 days between each period.\n\n        Exclusion Criteria:\n\n          -  Evidence of severe voiding dysfunction defined as:\n\n        More than 10 nocturnal voids per 24 hours as documented on any of the days in both diary\n        periods during screening.\n\n        More than 20 daytime voids per 24 hours as documented on any of the days in both diary\n        periods during screening.\n\n          -  Genito-urinary tract pathology that can in the investigator's opinion be responsible\n             for urgency or urinary incontinence e.g., symptomatic or recurrent urinary tract\n             infections, interstitial cystitis, bladder related pain, or stone in the bladder and\n             urethra causing symptoms\n\n          -  Current or a history within 5 years of lower urologic malignancies (e.g., bladder\n             cancer), lower urinary tract surgery, previous pelvic irradiation, or severe\n             neurological disease affecting bladder function or muscle strength (e.g., multiple\n             sclerosis, Parkinson's disease, spinal cord injury, spina bifida)\n\n          -  Symptoms of severe stress urinary incontinence in the opinion of the investigator\n\n          -  Urinary retention or a post void residual volume in excess of 150 mL as confirmed by\n             bladder ultrasound performed after suspicion of urinary retention\n\n          -  Habitual or psychogenic polydipsia (fluid intake resulting in a urine production\n             exceeding 40 mL/kg/24 hours) or a mean volume voided per void of 350 mL or more\n             during one or more 24-hour periods as assessed by the screening diaries\n\n          -  Central or nephrogenic diabetes insipidus\n\n          -  Syndrome of inappropriate antidiuretic hormone (SIADH)\n\n          -  Gastric retention\n\n          -  Myasthenia gravis\n\n          -  Uncontrolled narrow-angle glaucoma\n\n          -  Suspicion or evidence of cardiac failure\n\n          -  Uncontrolled and clinically relevant (in the judgement of the investigator)\n             hypertension or diabetes mellitus\n\n          -  History and/or current treatment of obstructive sleep apnoea\n\n          -  Hyponatraemia:Serum sodium level must not be below 135 mmol/L\n\n          -  Evidence of potential renal impairment:Serum creatinine must be within normal\n             laboratory reference intervals AND estimated glomerular filtration rate must be more\n             than or equal to 50 mL/min\n\n          -  Hepatic and/or biliary diseases: Aspartate aminotransferase and/or alanine\n             aminotransferase levels must not be more than twice the upper limit of normal range.\n             Total bilirubin level must not be more than 1.5 mg/dL\n\n          -  Pregnancy, breastfeeding, or a plan to become pregnant during the period of the\n             trial. Women of reproductive age must have documentation of a reliable method of\n             contraception. All pre- and perimenopausal women have to perform pregnancy tests.\n             Amenorrhea of more than 12 months duration based on the reported date of the last\n             menstrual period is sufficient documentation of post-menopausal status and does not\n             require a pregnancy test\n\n          -  Known alcohol or substance abuse; work or lifestyle that may interfere with regular\n             night-time sleep e.g., shift workers; or any other medical condition, laboratory\n             abnormality, psychiatric condition, mental incapacity, illiteracy or language barrier\n             which, in the judgement of the investigator, would impair participation in the trial\n\n          -  Known or suspected hypersensitivity to any active ingredient or excipients in the\n             investigational medicinal products used in the trial\n\n          -  Previous participation in any desmopressin trial within the last 5 years\n\n          -  Use of any prohibited therapy, as defined in the protocol"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01729819", 
            "org_study_id": "000085"
        }, 
        "intervention": [
            {
                "arm_group_label": "Tolterodine", 
                "intervention_name": "Tolterodine tartrate extended release capsules + Placebo orally disintegrating tablets", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Combination", 
                "intervention_name": "Tolterodine tartrate extended release capsules +  Desmopressin orally disintegrating tablets", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Deamino Arginine Vasopressin", 
                "Tolterodine", 
                "Phenylpropanolamine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 31, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Jonesboro", 
                        "country": "United States", 
                        "state": "Arkansas"
                    }, 
                    "name": "NEA Baptist Clinic"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas"
                    }, 
                    "name": "Lynn Institute of The Ozarks"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Urology Group of Southern California"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Moez Khorsandi, DO"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edgewater", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Riverside Clinical Research"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jupiter", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Health Awareness, Inc."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pembroke Pines", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Pines Clinical Research, Inc."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Palm Beach", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Palm Beach Research Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockbridge", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "Clinical Research Atlanta"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Evanston", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "Northshore Center for Gastroenterology"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "Remedica, LLC"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "The Urological Institute of Northeastern New York"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poughkeepsie", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Premier Medical Group of the Hudson Valley, P.C."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bethany", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }, 
                    "name": "Parkhurst Research Organization, LLC"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "Philadelphia Clinical Research, LLC"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "Medical University of South Carolina"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mount Pleasant", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "Coastal Carolina Research Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }, 
                    "name": "Vanderbilt University Medical Center"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Research Across America"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Advances in Health"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Pioneer Research Solutions, Inc."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Radiant Research"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia"
                    }, 
                    "name": "Clinical Research Associates of Tidewater"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "Seattle Women's: Health, Research, Gynecology"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multi-centre, Double-blind, Randomised Trial Investigating the Efficacy and Safety of a Combination Therapy, Desmopressin and Tolterodine, for Treatment of Overactive Bladder With Nocturia in Women", 
        "overall_contact": {
            "email": "DK0-Disclosure@ferring.com", 
            "last_name": "Clinical Development Support"
        }, 
        "overall_official": {
            "affiliation": "Ferring Pharmaceuticals", 
            "last_name": "Clinical Development Support", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in mean number of nocturnal voids from baseline", 
            "safety_issue": "No", 
            "time_frame": "during 3 months of treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01729819"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in mean time to first nocturnal void from baseline", 
                "safety_issue": "No", 
                "time_frame": "during 3 months of treatment"
            }, 
            {
                "measure": "Change in mean nocturnal urine volume from baseline", 
                "safety_issue": "Yes", 
                "time_frame": "during 3 months of treatment"
            }, 
            {
                "measure": "Responder status", 
                "safety_issue": "No", 
                "time_frame": "during 3 months of treatment"
            }, 
            {
                "measure": "Change in mean number of nocturnal voids from baseline for each visit", 
                "safety_issue": "No", 
                "time_frame": "during 3 months of treatment"
            }, 
            {
                "measure": "Change in the impact on sleep as measured by the sleep rating scales from baseline", 
                "safety_issue": "No", 
                "time_frame": "during 3 months of treatment"
            }
        ], 
        "source": "Ferring Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ferring Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}